October 22, 2007 - Cianna Medical recently announced that 100 patients have been treated with the SAVI applicator, a single-entry, multi-catheter applicator that delivers radiation therapy as part of breast conservation therapy.

By using a more precisely targeted dose of radiation, SAVI treats the tissue surrounding the lumpectomy cavity while minimizing radiation dose to healthy tissue. Instead of the six week course of treatment required by whole breast radiation, treatment with the SAVI applicator lasts just five days. This approach is becoming a more widely used alternative to whole breast irradiation, according to the manufacturer.

“SAVI is becoming a very important tool in the management of our breast cancer patients, because we can deliver breast brachytherapy to more patients than we could with its predecessor,” said Constantine Mantz, M.D., radiation oncologist with 21st Century Oncology.

“The great advantage of partial breast irradiation is that it expedites the course of radiation therapy that a woman would receive following surgery,” said Dr. Mantz. “Because SAVI is a multi-catheter device we can exert far greater control over how radiation is delivered in the breast. We have the luxury of being able to place the device very close to the skin or very close to the chest wall and still deliver a safe and effective treatment.”

Radiation treatment after a lumpectomy has traditionally involved irradiation of the entire breast with an external beam. This “whole breast irradiation” exposes more healthy tissue and involves a lengthy treatment course, with radiation delivered five times a week over a six-to-seven week period.

For more information: www.ciannamedical.com


Related Content

News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
News | Interventional Radiology

Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.

Time July 03, 2019
arrow
Technology | Focused Ultrasound Therapy

Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of Exablate Neuro to include the treatment of patients with tremor-dominant Parkinson's disease (PD).

Time December 21, 2018
arrow
Videos | Radiation Oncology

Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation ...

Time November 06, 2018
arrow
News | Radiation Dose Management

AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.

Time September 24, 2018
arrow
News | Radiation Oncology

World Cancer Day takes place annually on Feb. 4 to raise awareness and education in the media, governments and people ...

Time February 01, 2018
arrow
News | Oncology Related Products

December 19, 2016 — Children’s National Health System and Celsion Corp. announced in November the launch of a clinical ...

Time December 19, 2016
arrow
News | Clinical Decision Support

October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use ...

Time October 27, 2016
arrow
News | Ultrasound Imaging

September 12, 2016 — Tiny microbubbles are being used to more effectively identify liver tumors, according to a study ...

Time September 12, 2016
arrow
Subscribe Now